Ulcerative colitis and acute perimyocarditis

Kenneth K Cho, Yanna Ko, Kelly Nilsen, Christine Verdon and Giuseppe Femia
Med J Aust 2022; 216 (11): . || doi: 10.5694/mja2.51554
Published online: 20 June 2022


  • Campbelltown Hospital, Sydney, NSW

Competing interests:

No relevant disclosures.

  • 1. Brown G. 5‐Aminosalicylic acid–associated myocarditis and pericarditis: a narrative review. Can J Hosp Pharm 2016; 69: 466.
  • 2. Sehgal P, Colombel JF, Aboubakr A, Narula N. Systematic review: safety of mesalazine in ulcerative colitis. Aliment Pharmacol Ther 2018; 47: 1597‐1609.
  • 3. Varnavas VC, Reinsch N, Perrey M, et al. Recurrent lymphocytic myocarditis in a young male with ulcerative colitis. Eur J Med Res 2014; 19: 11.
  • 4. Fleming K, Ashcroft A, Alexakis C, et al. Proposed case of mesalazine‐induced cardiomyopathy in severe ulcerative colitis. World J Gastroenterol 2015; 21: 3376‐3379.
  • 5. Friedrich MG, Sechtem U, Schulz‐Menger J, et al. Cardiovascular magnetic resonance in myocarditis: a JACC white paper. J Am Coll Cardiol 2009; 53: 1475‐1487.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.